About US
Contact us
-
UK Government to provide additional £160m to Cancer Drugs FundThe UK Government is set to add an additional £160m to the Cancer Drugs Fund, in order to improve treatment for patients. The funding is intended to increase the grant from £200m a year t2014/9/1
-
Administrative Measures for Medical Device Registration and other four Administrative Measures issuedThe newly revised Regulations for the Supervision and Administration of Medical Devices was put into force on June 1, 2014. To support the implementation of the Regulations, China Food and Drug Admini2014/8/29
-
Novartis CEO Jimenez shrugs off biosimilars in the short termSwiss drugmaker Novartis ($NVS) last month became the first drugmaker to present the FDA with an application for abiosimilar, kicking off a new era in the U.S. that many believe will be a game changer2014/8/28
-
It's official: The Pfizer-AstraZeneca deal talk can resumeLet the speculation continue: The window to another Pfizer-AstraZeneca bidding round is now open, per U.K. takeover rules. As of Tuesday, AstraZeneca ($AZN) can legally invite Pfizer ($PFE) to negotia2014/8/27
-
PHEXCOM Events &Advertisement Cooperation 2015For the sake of providing better service to satisfy your demand, we prepared the “PHEXCOM Events and ADCooperation 2015”. More information please find the attachment. 1.5thPHEXFEST/China Pharmaceutic2014/8/26
-
Talk gets fevered over whether Pfizer, J&J or Lilly might make a run at CubistThe announcement that the FDA will review a second drug candidate from antibiotic specialist Cubist Pharmaceuticals ($CBST), speculation is ramping up that it is ripe for a takeover. Pfizer ($PFE), wh2014/8/25
-
GSK receives FDA approval for Arnuity™ Ellipta® (fluticasone furoate) in the USA for the treatment of asthma20 August 2014 GlaxoSmithKline plc today announced that the Food and Drug Administration has approved Arnuity™ Ellipta® (fluticasone furoate inhalation powder), a once-daily inhaled cortico2014/8/25
-
Roche negotiating for rest of Chugai for $10BA year ago, CEO Schwan said there was no need to buy the 40% it didn't own Just last month Roche CEO Severin Schwan indicated he wasn't interested in mega-deals to build his company, only smaller, mo2014/8/22
-
2014 PhexTour （Pharma Excipients Technical Application National Tour Seminar) 5nd station--Changchun2014 PhexTour （Pharma Excipients Technical Application National Tour Seminar) 5nd station--Changchun, was successfully concluded on August 7 at Jindu Hotel . More than 90 technical persons from 20 ph2014/8/21
-
2014 PhexTour （Pharma Excipients Technical Application National Tour Seminar) 4nd station--Tonghua2014 PhexTour （Pharma Excipients Technical Application National Tour Seminar) 4nd station--Tonghua, was successfully concluded on August 5 at East Holiday Hotel . More than 90 technical persons from2014/8/20